Attached files

file filename
EX-99.7 - EX-99.7 - QUEST DIAGNOSTICS INCdgx12312020ex997.htm
EX-32.2 - EX-32.2 - QUEST DIAGNOSTICS INCdgx12312020ex322.htm
EX-32.1 - EX-32.1 - QUEST DIAGNOSTICS INCdgx12312020ex321.htm
EX-31.2 - EX-31.2 - QUEST DIAGNOSTICS INCdgx12312020ex312.htm
EX-31.1 - EX-31.1 - QUEST DIAGNOSTICS INCdgx12312020ex311.htm
EX-21.1 - EX-21.1 - QUEST DIAGNOSTICS INCdgx12312020ex211.htm
EX-10.17 - EX-10.17 - QUEST DIAGNOSTICS INCdgx12312020ex1017.htm
EX-10.15 - EX-10.15 - QUEST DIAGNOSTICS INCdgx12312020exh1015.htm
EX-10.5 - EX-10.5 - QUEST DIAGNOSTICS INCdgx12312020ex105.htm
EX-10.4 - EX-10.4 - QUEST DIAGNOSTICS INCdgx12312020ex104.htm
10-K - 10-K - QUEST DIAGNOSTICS INCdgx-20201231.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-232138) and Form S-8 (Nos. 333-184580, 333-182863, 333-143889, 333-136196, 333-60758, 333-60477, 333-157447, 333-162710, 333-162711, 333-207746, 333-214215, 333-221076 and 333-234328) of Quest Diagnostics Incorporated of our report dated February 22, 2021 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

By/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 22, 2021